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  NON-AQUEOUS TITRIMETRIC ASSAY OF 
GABAPENTIN IN CAPSULES USING 
PERCHLORIC ACID AS TITRANT 
Two simple, rapid, accurate and inexpensive methods using visual and poten-
tiometric titrimetric techniques are described for the determination of gabapen-
tin (GBP) in bulk drug as well as in capsules. The methods are based on the 
neutralization reaction of the primary amino group of GBP with acetous per-
chloric acid as titrant in anhydrous acetic acid medium. The end point was de-
tected either visually using crystal violet as indicator or potentiometrically using 
a modified glass electrode SCE electrode system. Both methods are appli-
cable over the range 1.0-16.0 mg of GBP and the titration reaction follows a 
1:1 stoichiometry. The methods were successfully applied to the determination 
of GBP in capsules. The validity of the proposed methods was further ascer-
tained by parallel determination by a reference method and by recovery stu-
dies via standard-addition technique. 
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Gabapentin (GBP), chemically known as 1-(ami-
nomethyl)cyclohexaneacetic acid [1], is an antiepilep-
tic drug related to γ-butyric acid. Gabapentin crosses 
the blood brain barrier and is employed for the treat-
ment of partial seizures. Gabapentin has demons-
trated analgesic effects in patients with chronic neuro-
pathic pain states [2]. Several analytical methods have 
been reported for the determination of gabapentin in 
pharmaceutical preparations such as high perfor-
mance liquid chromatography (HPLC) [3-8], capillary 
electrophoresis [9,10], chemiluminometry [11], poten-
tiometry [2], voltammetry [12], spectrofluorimetry 
[13,14], spectrophotometry [15-20], automated spec-
trophotometry using piezoelectric pumping [21] and 
fluorimetry using sequential injection [22].  
To the best of our knowledge, no titrimetric me-
thod has ever been reported for the determination of 
GBP in pharmaceuticals. The previously reported me-
thods are applicable only over the microgram level, 
however, they are sensitive, most of them are time 
consuming, require multistage procedures, long reac-
tion time for colour development and require expen-
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sive instrumental setup. The non-aqueous titrations 
have become of considerable importance in pharma-
ceutical analysis and have been accepted by the ma-
jority of modern pharmacopoeias as an official analy-
tical method such as British pharmacopoeia (2009) 
[23]. In addition, the non-aqueous titration technique 
is very simple and easily adoptable to determine the 
GBP content in milligram level in the quality control 
laboratories across the developing countries where 
modern and expensive instruments are not available. 
The present work describes two simple and ac-
curate titrimetric procedures for the determination of 
GBP in pure drug as well as in capsules. The me-
thods involve the titration of acetous solution of GBP 
with acetous perchloric acid in acetic acid medium 
and the end point being detected either visually using 
crystal violet as indicator or potentiometrically using 
combined glass electrode.  
EXPERIMENTAL 
Apparatus 
An Elico 120 digital pH meter provided with a 
combined glass-SCE electrode system (Equip-Tro-
nics, Mumbai, India) was used for potentiometric tit-
ration. The salt bridge was filled with saturated solu-
tion of potassium chloride in glacial acetic acid. 
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Materials and reagents 
Pharmaceutical grade gabapentin (GBP) which 
is reported to be 99.5% pure with a lot No. 
(G11010609) was received from Sun Pharmaceuti-
cals, Mumbai, India. The following pharmaceutical 
preparations were purchased from commercial sour-
ces in the local market and subjected to analysis: 
Gabantin-100 (100 mg GBP per capsule) from Sun 
Pharma Sikkim, Ranipool, East Sikkim, India and Ga-
bapin-300 (300 mg GBP per capsule) from Intas 
Pharmaceuticals, Dehradun, India. 
All chemicals used were of analytical-reagent 
grade and the solutions were prepared as follows. 
Perchloric acid (0.01 M): the commercially avail-
able 0.1 M perchloric acid (Merck, Mumbai, India) 
was appropriately diluted with the glacial acetic acid 
(Merck, Mumbai, India, sp.gr. 1.05) to get 0.01 M per-
chloric acid and it was standardized against 0.01 M 
potassium dihydrogen phthalate [24]. 
Crystal violet indicator: a 0.2 % crystal violet 
(Qualigens Fine Chemicals, Mumbai, India, 85.0% 
dye content) indicator was prepared by dissolving 
58.8 mg of the dye in 25 ml of glacial acetic acid.  
Preparation of standard GBP solution: a stock 
standard solution containing 2.0 mg ml-1 GBP was 
prepared by dissolving accurately weighed 200 mg of 
pure GBP in glacial acetic acid and diluted to the 
mark in a 100 ml calibrated flask with the same acid. 
Assay procedures 
Visual titration 
Different volumes (0.5-8.0 ml) of standard so-
lution containing 2.0 mg ml-1 GBP were taken in a 100 
ml dry titration flask and the volume was made up to 
10 ml with glacial acetic acid. Two drops of 0.2 % 
crystal violet indicator were added and the solution 
was titrated with standard solution of 0.01 M perchlo-
ric acid to a pure blue end point. A blank titration was 
performed in the same manner without drug, and the 
necessary corrections were made. 
Potentiometric titration 
An aliquot of the standard drug solution con-
taining 1.0-16.0 mg of GBP was transferred into a 50 
ml dry beaker and the solution was diluted to 25 ml by 
adding glacial acetic acid. A modified glass-saturated 
calomel electrode was dipped in the solution; the con-
tent was stirred magnetically and titrated with 0.01 M 
HClO4 from a micro burette. Near the equivalence 
point, the titrant was added in 0.05 ml increments and 
after each addition of titrant, the solution was stirred 
for 30 s and the steady potential was recorded. The 
titration was continued until there was no significant 
change in the potential on further addition of the tit-
rant. The equivalence point was determined by apply-
ing the graphical method using first derivative plot 
(Figure 1). 
 
Figure 1. First derivative potentiometric titration curve for the 
titration of 10 mg of GBP with 0.01 M HClO4. 
In both methods, the amount of GBP in the mea-
sured aliquot was computed from the following formula: 
Amount(mg)=
V Mw S
n
× ×
 
where V = ml of the perchloric acid reacted, Mw = re-
lative molecular mass of GBP, S = molarity of per-
chloric acid and n = number of moles of perchloric 
acid reacting with each mole of GBP. 
Assay procedure for capsules 
The content of ten capsules each containing 100 
or 300 mg of GBP were weighed. An accurately 
weighed quantity equivalent to 200 mg of GBP was 
transferred into a 100 ml calibrated flask and dis-
solved in 60 ml glacial acetic acid.  The contents of 
the flask were shaken for 15 min; the volume was 
diluted to the mark with the same acid, mixed well 
and filtered using a Whatman No. 42 filter paper. The 
first 10 ml portion of the filtrate was discarded and a 
suitable aliquot of the filtrate (2.0 mg ml-1 GBP) was 
subjected to analysis following the procedures des-
cribed for both methods.  
RESULTS AND DISCUSSION 
Non-aqueous titrations are widely used in the 
British Pharmacopoeia, Volumes I and II, for the as-
say of many drug substances based on the properties 
of the drug which is either weakly acidic or weak 
bases [25]. The proposed methods are based on the 
neutralization reaction of the primary amino group of 
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the weak base gabapentin with perchloric acid as a 
titrant in glacial acetic acid medium. The acetic acid is 
mostly employed as a solvent for such type of titration 
due to its protophillic and protogenic properties, and 
its ability to donate protons and accept protons [26] as 
follows: 
CH3COOH  H+ + CH3OO- 
When a strong acid, such as perchloric acid, is 
dissolved in a weaker acid, such as acetic acid, the 
acetic acid is forced to act as a base and accept a 
proton from the perchloric acid forming an onium ion 
[25]. The formed onium ion (CH3COOH2
+) can very 
readily give up its proton to react with GBP, so basic 
property of the drug is enhanced and hence, titration 
between GBP and perchloric acid can often be accu-
rately carried out using acetic acid as solvent. The 
reactions occurring are as follows: 
The detection of the end point in the visual me-
thod was done by using crystal violet as indicator and 
the colour change from violet to pure blue being taken 
as the end point. Also, the detection of the end point 
in the potentiometric method was accomplished by 
using combined glass electrode and the end point was 
taken at the sudden jump in the potential. The reac-
tion stoichiometry was found to be 1:1 (GBP:HClO4) 
in the range studied (1.0-16.0 mg GBP) for both me-
thods and this ratio was served as the basis for the 
calculations. 
Method validation 
The method validation was done according to 
the present ICH guidelines [27]. 
Accuracy and precision 
The precision of the methods was calculated in 
terms of intermediate precision (intra-day and inter-day) 
[28]. Three different amounts of GBP were analysed 
in seven replicates during the same day (intra-day 
precision) and five consecutive days (inter-day preci-
sion). The percentage relative standard deviation (RSD, 
%) values were ≤1.14% (intra-day) and ≤1.34% (inter-
day) indicating high precision of the methods. Also, 
the accuracy of the methods was evaluated as per-
centage relative error (RE, %) and from the results 
shown in Table 1, it is clear that the accuracy is satis-
factory (RE ≤ 1.47%).  
Selectivity 
To determine the selectivity of the methods, the 
analytical placebo blank was prepared and subjected 
to analysis by the proposed methods. It was con-
firmed that the change in the titre value with respect 
to the acetic acid blank was caused only by the ana-
lyte. To identify the interference by common formula-
tions excipients, a synthetic mixture with the compo-
sition: GBP (500 mg), talc (100 mg), corn starch (200 
mg), calcium gluconate (100 mg), lactose (250 mg), 
sodium alginate (50 mg) and magnesium stearate (30 
mg), was prepared and subjected to analysis by the 
proposed methods after solution preparation following 
the procedure described for capsules. The percent 
recoveries of GBP were 102.81±1.04 (n = 5) and 
101.90±1.63 (n = 5) by visual method and potentio-
metric method, respectively, suggesting no interfe-
rence by the excipients in the assay of GBP under the 
described conditions. 
 
Overall, the reaction is: 
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Application to the assay of capsules 
The proposed methods were successfully ap-
plied to the determination of GBP in capsules (Table 
2). The results obtained were statistically compared 
with those of the reference method [15] by applying 
the Student’s t-test for accuracy and F-test for preci-
sion. The reference method consisted of the measu-
rement of the absorbance of the aqueous extract of 
the capsules at 210 nm. In all the cases, the average 
results obtained by the proposed methods and refe-
rence method were statistically identical, as the diffe-
rence between the average values had no signifi-
cance at 95 % confidence level with respect to accu-
racy and precision. 
Recovery study 
To ascertain the validity of the proposed me-
thods, a recovery experiment was performed via stan-
dard addition technique. To a fixed and known amount 
of drug in capsule powder (pre-analyzed), pure drug 
was added at three levels (50, 100 and 150% of the 
level present in the capsule) and the total was mea-
sured by the proposed methods. The determination 
with each amount was repeated three times and the 
results of this study presented in Table 3 indicated 
that the various excipients present in the formulations 
did not interfere in the assay. 
CONCLUSIONS 
This is the first report on the assay of gaba-
pentin in formulations by titrimetry. The assay results 
demonstrate that it is possible to determine the GBP 
in capsules by titration in non-aqueous medium using 
perchloric acid. In particular, the titrimetry is much 
simpler in technique, more rapid than all the previous 
Table 1. Evaluation of intra-day and inter-day precision and accuracy 
Method GBP taken, mg 
Intra-day (n = 7) Inter-day (n = 5) 
GBP founda, mg RSDb / % REc / % GBP founda, mg RSDb / % REc / % 
Visual method 4.00 
8.00 
12.00 
3.97 
7.90 
11.88 
1.07 
0.62 
0.90 
0.75 
1.25 
1.00 
3.96 
7.93 
11.90 
1.26 
0.79 
1.02 
1.00 
0.88 
0.83 
Potentiometric method 5.00 
10.00 
15.00 
5.06 
10.07 
15.22 
1.14 
0.93 
1.08 
1.20 
0.70 
1.47 
5.05 
10.09 
15.17 
1.34 
1.02 
1.22 
1.00 
0.90 
1.13 
aMean value of n determinations; brelative standard deviation; cbias: ((found – taken) / taken)×100. 
Table 2. Comparison of assay results of proposed and reference methods (mean value of five determinations) 
Capsule brand name Nominal amount, mg 
Found, % (of nominal amount±SD) 
Reference method 
Proposed methods 
Visual method Potentiometric method 
Gabantin-100 100 100.80±0.84 99.65±1.05 
ta = 1.91 
Fb = 1.56 
101.83±1.19 
t = 1.58 
F = 2.01 
Gabapin-300 300 99.91±1.15 98.23±0.78 
t = 2.70 
F = 2.17 
99.02±1.43 
t = 1.08 
F = 1.55 
aTabulated t-value at the 95% confidence level is 2.78; btabulated F-value at the 95% confidence level is 6.39 
Table 3. Results of recovery study using the standard-addition method 
Formulation studied 
Visual method Potentiometric method 
GBP in 
capsule, mg 
Pure GBP 
added, mg 
Total found
mg 
Pure GBP re-
covereda±SD, %
GBP in 
capsule, mg
Pure GBP 
added, mg 
Total found 
mg 
Pure BUP H re-
covereda±SD, % 
Gabantin-100 3.98 
3.98 
3.98 
2.00 
4.00 
6.00 
5.95 
7.89 
9.93 
98.50±2.45 
97.75±1.23 
99.17±0.86 
4.07 
4.07 
4.07 
2.00 
4.00 
6.00 
6.05 
8.00 
10.10 
99.00±1.86 
98.25±2.02 
100.50±1.21 
Gabapin-300 5.89 
5. 89 
5. 89 
3.00 
6.00 
9.00 
8.91 
11.87 
14.75 
100.67±1.63 
99.67±0.74 
98.44±1.08 
5.94 
5.94 
5.94 
3.00 
6.00 
9.00 
8.99 
12.07 
14.90 
101.67±2.31 
102.17±1.97 
99.56±1.66 
aMean value of three determinations 
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reported methods so far for the assay of GBP. The 
proposed methods are applicable over a wide range 
(1.0-16.0 mg of GBP) and provide very accurate and 
precise results. Although several instrumental tech-
niques have been reported for the assay of GBP in 
pharmaceuticals they suffer from such drawbacks 
such as time consuming, require multistage procedu-
res and require expensive instrumental setup. The 
wide applicability of the new procedures for routine 
quality control is well established by the assay of GBP 
in pure form and in capsules. 
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NAUČNI RAD 
  TITRACIONA ANALIZA GABAPENTINA U KAPSU-
LAMA PRIMENOM PERHLORNE KISELINE KAO 
TITRANTA U NEVODENOJ SREDINI 
Opisane su dve jednostavne, tačne i jeftine titracione metode za određivanje gabapen-
tina (GBP) u rasutom stanju droge, kao i u kapsulama. Metode se zasnivaju na reakciji 
neutralizacije primarne amino grupe GBP perhlornom kiselinom u glacijalnoj sirćetnoj ki-
selini. Završne tačke su određene titracijom uz kristal violet kao indikator ili potencio-
metrijskom titracijom koristeći elektrodni sistem koji se sastoji od modifikovane staklene i 
ZKE elektrode. Reakcije se odigravaju u stehiometrijskom odnosu 1:1. Obe metode su 
uspešno primenjene za određivanje GBP u kapsulama u opsegu 1,0-16,0 mg. Validnost 
predloženih metoda je dodatno potvrđena paralelnim određivanjem referentnom meto-
dom i određivanjem procentnog prinosa (recovery vrednosti) metodom standardnog do-
datka. 
Ključne reči: ispitivanje gabapentina; titrimetrija; potenciometrija; kapsula. 
 
 
